This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Authoring team

Prognosis can vary widely but appears to be most dependent on treatment (1)

  • Several randomized, controlled trials have shown that untreated autoimmune hepatitis patients have a 5-year and 10-year survival rate of 50% and 10%, respectively.
  • 60% to 80% of patients will enter remission after the proposed duration of treatment
    • approximately 50% of these patients will relapse requiring therapy resumption

Some patients require life-long immunosuppression.

Treatment failure occurs in 10% of patients that undergo treatment with prednisone.

Those who undergo liver transplantation, approximately a third of patients have a recurrence of autoimmune hepatitis.

Reference:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.